210 related articles for article (PubMed ID: 33693866)
1. Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice.
Knudsen C; Neyrinck AM; Leyrolle Q; Baldin P; Leclercq S; Rodriguez J; Beaumont M; Cani PD; Bindels LB; Lanthier N; Delzenne NM
J Nutr; 2021 Jun; 151(6):1507-1516. PubMed ID: 33693866
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
3. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
[TBL] [Abstract][Full Text] [Related]
4. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
5. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
J Obes; 2013; 2013():296537. PubMed ID: 23401753
[TBL] [Abstract][Full Text] [Related]
6. Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.
Rodríguez A; Moreno NR; Balaguer I; Méndez-Giménez L; Becerril S; Catalán V; Gómez-Ambrosi J; Portincasa P; Calamita G; Soveral G; Malagón MM; Frühbeck G
Sci Rep; 2015 Jul; 5():12067. PubMed ID: 26159457
[TBL] [Abstract][Full Text] [Related]
7. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.
Ding Y; Yanagi K; Yang F; Callaway E; Cheng C; Hensel ME; Menon R; Alaniz RC; Lee K; Jayaraman A
Elife; 2024 Feb; 12():. PubMed ID: 38412016
[TBL] [Abstract][Full Text] [Related]
8. Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3.
Ma L; Li H; Hu J; Zheng J; Zhou J; Botchlett R; Matthews D; Zeng T; Chen L; Xiao X; Athrey G; Threadgill DW; Li Q; Glaser S; Francis H; Meng F; Li Q; Alpini G; Wu C
Hepatology; 2020 Oct; 72(4):1191-1203. PubMed ID: 31953865
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.
Suriano F; Vieira-Silva S; Falony G; Roumain M; Paquot A; Pelicaen R; Régnier M; Delzenne NM; Raes J; Muccioli GG; Van Hul M; Cani PD
Microbiome; 2021 Jun; 9(1):147. PubMed ID: 34183063
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
12. Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.
Haub S; Ritze Y; Ladel I; Saum K; Hubert A; Spruss A; Trautwein C; Bischoff SC
J Pharmacol Exp Ther; 2011 Dec; 339(3):790-8. PubMed ID: 21903748
[TBL] [Abstract][Full Text] [Related]
13. The combination of Ilexhainanoside D and ilexsaponin A
Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
[TBL] [Abstract][Full Text] [Related]
15. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury.
Bruno RS; Dugan CE; Smyth JA; DiNatale DA; Koo SI
J Nutr; 2008 Feb; 138(2):323-31. PubMed ID: 18203899
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
17. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
18. [Effects of bifid triple viable on chronic low-grade inflammation in obese mice induced by high fat diet].
Lu M; Yuan L; Hu N; Zhong X; Jiang Y; Lin M; Lu X
Wei Sheng Yan Jiu; 2022 Sep; 51(5):797-802. PubMed ID: 36222043
[TBL] [Abstract][Full Text] [Related]
19. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
Kim S; Choi S; Dutta M; Asubonteng JO; Polunas M; Goedken M; Gonzalez FJ; Cui JY; Gyamfi MA
Biochem Pharmacol; 2021 Nov; 193():114698. PubMed ID: 34303710
[TBL] [Abstract][Full Text] [Related]
20. Effects of bile acid sequestration on hepatic steatosis in obese mice.
Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
